X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Clinical Diagnostics Companies

This report lists the top Clinical Diagnostics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Clinical Diagnostics industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Clinical Diagnostics Top Companies

  1. Bio-Rad Laboratories

  2. Danaher

  3. Roche

  4. Abbott Laboratories

  5. bioMérieux

*Disclaimer: Top companies sorted in no particular order

Clinical Diagnostics Market Major Players

Clinical Diagnostics Market Concentration

Clinical Diagnostics  Market Concentration

Clinical Diagnostics Company List

                              • Abbott Laboratories

                              • Becton, Dickinson and Company

                              • BioMerieux

                              • Bio-Rad Laboratories Inc.

                              • Danaher Corporation

                              • Siemens AG

                              • Hologic Inc.

                              • Qiagen NV

                              • F. Hoffmann-La Roche AG

                              • Thermo Fisher Scientific

                              • Quest Diagnostics Inc.

                              • Sysmex Corporation

                              • Sonic Healthcare Ltd

                              • Charles River Laboratories


                          Specific to Clinical Diagnostics Market
                          Need More Details On Market Players And Competitors?
                          Download PDF

                          Clinical Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)